Vanguard Capital Management’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.1M Buy
136,753
+2,218
+2% +$158K ﹤0.01% 2748
2026
Q2
$9.28M Sell
134,535
-4,025
-3% -$268K ﹤0.01% 2858
2026
Q1
$8.59M Buy
+138,560
New +$8.73M ﹤0.01% 2814

Other funds holding UTMD

Vanguard Capital Management's UTMD Position: Q3 2026 in Review

Vanguard Capital Management increased its Utah Medical Products (UTMD) stake by 1.6% in Q3 2026, buying an estimated $158K and bringing the position to 136,753 shares worth $10.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2748.

Vanguard Capital Management first reported a position in UTMD in Q1 2026 and has held it in 3 quarters since. 98 funds tracked by Wall St. Rank hold UTMD as of Q3 2026.

  • Vanguard Capital Management held 136,753 shares of Utah Medical Products worth $10.1M as of Q3 2026.
  • Vanguard Capital Management bought 2,218 Utah Medical Products shares in Q3 2026, an estimated $158K.
  • Utah Medical Products made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2748 holding.
  • Vanguard Capital Management first reported a position in Utah Medical Products in Q1 2026 and has held it in 3 quarters since.
  • 98 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.